proteinmetrics.com 的前十大競爭對手

pfind.ict.ac.cn

pfind studio: a computational solution for mass spectrometry-based proteomics. pfind是目前国内唯一的具有自主知识产权的蛋白质鉴定引擎。我们是中科院计算所pfind团队，开发了蛋白质鉴定引擎pfind，以及一系列质谱数据分析软件。我们最近在nature methods期刊上发表了文章，这是国内蛋白质组学第一篇。

proteomics.com.au

Jordana Sheahan, Iris Wang, Peter Galettis, Scott Bringans, David Watson, Kirsten Peters, Richard Lipscombe Diseases of the Esophagus, Volume 38, Issue Supplement_1, August 2025, doaf061.017, https://doi.org/10.1093/dote/doaf061.017 Published: 14 August 2025 Abstract Background: Esophageal adenocarcinoma (EAC) is often diagnosed at an advanced stage, leading to poor prognosis. The current standard of care involves endoscopy with biopsy in at-risk populations, which is invasive and expensive, yet increasing endoscopic surveillance programs have failed to significantly reduce EAC mortality. Significant to patient management, the pre-cancerous condition Barrett’s Esophagus with high grade dysplasia (BE-HGD) is often treated promptly upon detection similarly to early stage EAC. This study evaluates an alternative diagnostic strategy using the blood test Promarker®Eso, a previously validated serum glycoprotein biomarker panel for EAC, to detect EAC from stage I-IV and BE-HGD. Methods: The study analysed 350 people across two independent cohorts: cohort A compared 89 healthy controls with EAC samples of known stage (I: n = 16, II: n = 23, III: n = 16, IV: n = 3); cohort B compared 40 negative controls with unstaged EAC (n = 48) with n = 115 BE samples. The multivariate PromarkerEso test measures four glycoprotein biomarker concentrations (alpha-1-antitrypsin, alpha-1-antichymotrypsin, complement C9 and plasma kallikrein) using a lectin-based magnetic bead array pulldown method with targeted mass spectrometry, combined with simple clinical data (age, sex, BMI). Samples are categorised by predicted probability scores as low- (75%) risk of having EAC. Results: PromarkerEso exhibited robust discrimination performance for all stages of EAC with a minimum area under the curve (AUC) of 0.97. Concurrently, the test exhibited high sensitivity for EAC in all stages (I: 81%, II: 91%, III: 100%; IV: 100%) and also for BE-HGD (93%). Additionall

caprotec.com

charles river provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

proteincentre.com

Quantification of low molecular weight sugars by UPLC-MRM-MS

matrixscience.com

mascot software from matrix science - identification, characterisation and quantitation of proteins using mass spectrometry data

psidev.info

HUPO-PSI is a global effort to develop and maintain community-driven standards, data formats, and controlled vocabularies for proteomics and mass spectrometry-based research.